Friday, 21 December 2012

Stemedica Cell Technologies has been issued stem cell patent for the treatment of diabetic retinopathy and optic neuropathy

Today, Stemedica Cell Technologies announced that it has been issued ,by the United States Patent Office, a broad patent for the stem cell treatment it offers for diabetic retinopathy, diabetic optic neuropathy  as well as other degenerative diseases of the eye.

The patent was issued after the results of a six patient clinical study that was conducted by Natalia Gavrilova. During the study, all patients showed great improvements in the function of the optic nerve and blood flow in the eye. No adverse effects were reported and all patients stayed stable during the follow up period.

Paul Tornambe, M.D., of Retinal Consultants Inc., made the following statement

 “These preliminary data are encouraging. As we seek to find the best treatments for diabetic retinopathy, it is important to explore many different approaches including combined stem cell treatment.”

Diabetic retinopathy is a medical term referring to retina damage caused by complications of diabetes, many times leading to blindness. In the USA, it is the number one cause of blindness in the age group of 25-75 years of age. Every year, around 70.000 people are diagnosed with the condition, with an estimated total of 700.000 people suffering from the condition.

Stemedica Cell Technologies is a global biopharmaceutical company  developing and manufacturing  allogeneic stem cells. They are one of the few companies that are actually approved for clinical trial applications. Their facilities are located at San Diego, California.

Promotional Video of Stemedica's stem cell technology

You can read the official press release here

No comments:

Post a Comment

Please note that we dont offer any kind of medical advice. Questions requesting specific medical advice (e.g. where can I get this treatment, will this cure XXX condition, etc) will be published but most probably ignored by the administrators. :)

Note to spammers: You shall not pass. If you really want a link from us then consider making a stem cell related guest post !